Is Cancer Research Money Well Spent?

Cancer Research Donations Wasted By Inefficient R&D System
When we give money to cancer research charities like Cancer Research UK we expect that money to be used efficiently but less than 2% is likely to be spent on researching new drugs that can be given to NHS cancer patients as a routine treatment.

Read More


Time To Rethink How We Pay for Medical Research

Financing Medical Research
Our medical R&D system is undermining our health – reform could boost our economy and our wellbeing. It’s time we implemented a new, more efficient, collaboratively driven, open innovation model with patient needs at its heart.

Read More


Are We Being Misled On Cancer Progress?

Cancer Survival Rates Are Misleading
Evidence has come to light that the public may be being misled about our progress on beating cancer and that progress is almost certainly not as good as that implied by the much touted cancer survival statistics.

Read More


95% of Promising Cancer Research Fails

We need to fix the cancer R&D system
The British public pays £2.5bn a year towards the cost of developing new drugs for cancer, but 95% of cancer research discoveries don't work in patients and half of the 5% that do the NHS can't afford. Is this money well spent?

Read More


NHS Can’t Afford Half New Cancer Drugs

Profits On Cancer Drugs Are Killing Us
Half of new cancer drugs are too pricey for the NHS due to profiteering by drug companies. The Government is choosing to leave patients to die early rather than exercise its legal powers to obtain the newer, more effective drugs from a cheaper alternative source.

Read More


Cancer Drug Benefits Are Overhyped

Cancer Cure Hype
Barely a month goes by without a newspaper headline hailing the latest “Major cancer breakthrough”, but dig beneath the media hype and you’ll discover the shocking reality that new cancer drugs for most cancers are only expected to improve patient survival by just 2.7 months on average.

Read More


Cancer Drug Costs Could Be Halved

Cancer Drug Price Solution
The cost of developing new cancer drugs could be halved at least if we cooperated across the world to publicly fund R&D, using cheaper finance, eliminating wasteful duplication and developing drugs for public benefit not for profit.

Read More


Open Letter to World Leaders

Cancer Letter to World Leaders
An open letter from the Dying for a Cure campaign to World Leaders about cancer. If we truly want to beat cancer sooner, we need to cooperate across the world to use our money, knowledge and skills more wisely - for public benefit, not for profit.

Read More


Cancer Drugs Fund Was Short-Sighted

Cancer Drugs Fund Fuels Price Rises
The Cancer Drugs Fund was put forward by David Cameron during the 2010 General Election campaign – a tempting olive branch for many cancer patients desperate for expensive life-saving drugs but in reality a short-sighted, vote-winning gesture that has helped to make drugs even more unaffordable in the longer term.

Read More


£99 Cancer Drug Being Sold for £83,000

Cancer Drug Profiteering
Shocking new evidence has come to light of massive profiteering from cancer drugs - one cancer drug that costs only £99 to make is being being sold for up to £83,000, despite R&D costs being paid back over 10 years years ago.

Read More